Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBF.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.58NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.58NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.631NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.631NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.631NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.627NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.627NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.627NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.519NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.519NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.519NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.514NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.514NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.514NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.87NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.87NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.87NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAPNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAPNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.6.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.47.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.47.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.47.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used